Merck's Momentum Falters as Price Weakness Persists

Merck's recent rebound is still uncertain as its momentum weakens. The stock is trading above its short- and medium-term averages, but buyers are not yet dominant. This matters for a large defensive name like Merck because it suggests the presence of buyers without sufficient conviction.

Trend indicators show that Merck is moving upward, but with limited force to call it a decisive trend. The stock's price sits above its SMA20 at $148.59 and well above SMA50 at $138.39, indicating a constructive setup for the medium term.

However, the chart still shows a sideways market with a relatively flat slope of 0.25% over five days. This distinction is crucial as a sideways market can appear healthy but remain vulnerable to reversals if buyers lose conviction.